Analysis of dose-volume parameters predicting radiation pneumonitis in patients with esophageal cancer treated with 3D-conformal radiation therapy or IMRT

Japanese Journal of Radiology

Volumn 30, Issue 1, 2012, Pages 18-24

  Kumar, Gaurav ^a   Rawat, Sheh ^a   Puri, Abhishek ^a   Sharma, Manoj Kumar ^a   Chadha, Pranav ^b   Babu, Anand Giri ^a   Yadav, Girigesh ^a  

^a RAJIV GANDHI CANCER INSTITUTE AND RESEARCH CENTRE   (India)

^b MEDANTA THE MEDICITY   (India)

Author keywords

Dose volume histogram; Esophageal carcinoma; Intensity modulated radiotherapy; Pulmonary toxicity; Radiation pneumonitis

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ESOPHAGUS CANCER; FEMALE; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; LUNG FUNCTION TEST; LUNG VOLUME; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PNEUMONIA; ACUTE DISEASE; CHRONIC DISEASE; COMPUTER ASSISTED RADIOTHERAPY; ESOPHAGUS TUMOR; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; RADIATION RESPONSE; STATISTICS;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, RADIATION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX;

EID: 84862314257     PISSN: 18671071     EISSN: 1867108X     Source Type: Journal    
DOI: 10.1007/s11604-011-0002-2     Document Type: Article

References (38)

1. Al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, et al. Progress report of combined chemo-radiotherapy versus radiotherapy alone in patients with esoph-ageal cancer: an intergroup study. J Clin Oncol. 1997;15: 277-84. (Pubitemid 27020584)
2. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the oesophagus. N Engl J Med. 1997;337:161-7. (Pubitemid 27306287)
3. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326:1593-8.
4. Tucker SL, Liu HH, Wang S, Wei X, Liao Z, Komaki R, et al. Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys. 2006;66:754-61. (Pubitemid 44436709)
5. Lee HK, Vaporciyan AA, Cox JD, Tucker SL, Putnam JB Jr, Ajani JA, et al. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correla-tion with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys. 2003;57:1317-22. (Pubitemid 37443971)
6. Wang SL, Liao Z, Vaporciyan AA, Tucker SL, Liu H, Wei X, et al. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal can-cer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys. 2006;64:692-9. (Pubitemid 43183562)
7. Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esopha-geal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20:1167-74. (Pubitemid 34177421)
8. Nutting CM, Bedford JL, Cosgrove VP, Tait DM, Dearnaley DP, Webb S, et al. A comparison of conformal and intensity-modu-lated techniques for oesophageal radiotherapy. Radiother Oncol. 2001;61:157-63. (Pubitemid 33016575)
9. Bedford JL, Viviers L, Guzel Z, Childs PJ, Webb S, Tait DM, et al. A quantitative treatment planning study evaluating the potential of dose escalation in conformal radiotherapy of the oesophagus. Radiother Oncol. 2000;57:183-93.
10. Guzel Z, Bedford JL, Childs PJ, Nahum AE, Webb S, Oldham M, Tait D, et al. A comparison of conventional and conformal radiotherapy of the oesophagus: work in progress. Br J Radiol. 1998;71:1076-82.
11. Nutting C, Dearnaley DP, Webb S. Intensity modulated radiation therapy: a clinical review. Br J Radiol. 2000;73:459-69. (Pubitemid 30311486)
12. Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys. 1989;16:1623-30. (Pubitemid 19154353)
13. Lyman JT. Complication probability as assessed from dose- volumehistograms. RadiatRes. 1985;104:S13-9.
14. Zaider M, Amols HI. A little to a lot or a lot to a little: is NTCP always minimized in multiport therapy? Int J Radiat Oncol Biol Phys. 1998;41:945-50. (Pubitemid 28285977)
15. Seppenwoolde Y, Lebesque JV, de Jaeger K, Belderbos JS, Boersma LJ, Schilstra C, et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Int J Radiat Oncol Biol Phys. 2003;55:724-35. (Pubitemid 36170012)
16. Tsujino K, Hirota S, Endo M, Obayashi K, Kotani Y, Satouchi M, et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys. 2003;55:110-5. (Pubitemid 36020349)
17. Kwa SL, Lebesque JV, Theuws JC, Marks LB, Munley MT, Bentel G, et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys. 1998;42:1-9. (Pubitemid 28435589)
18. Martel MK, Ten Haken RK, Hazuka MB, Turrisi AT, Fraass BA, Lichter AS, et al. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys. 1994;28:575-81. (Pubitemid 24072740)
19. Söderström S, Brahme A. Which is the most suitable number of photon beam portals in coplanar radiation therapy? Int J Radiat Oncol Biol Phys. 1995;33:151-9.
20. Stein J, Mohan R, Wang XH, Bortfeld T, Wu Q, Preiser K, et al. Number and orientations of beams in intensity-modulated radia-tion treatments. Med Phys. 1997;24:149-60. (Pubitemid 27084021)
21. Common Terminology Criteria for Adverse Events Version 3 (CTCAE v3). Published in August 2006.
22. Kam MK, Chau RM, Suen J, Choi PH, Teo PM. Intensity-mod-ulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose esca-lation. Int J Radiat Oncol Biol Phys. 2003;56:145-57. (Pubitemid 36403686)
23. Gopal R, Tucker SL, Komaki R, Liao Z, Forster KM, Stevens C, et al. The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys. 2003;56:106-13. (Pubitemid 36403681)
24. Smith TJ, Ryan LM, Douglass HO Jr, Haller DG, Dayal Y, Kirkwood J, et al. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys. 1998;42:269-76. (Pubitemid 28502772)
25. Sykes AJ, Burt PA, Slevin NJ, Stout R, Marrs JE. Radical radiotherapy for carcinoma of the oesophagus: an effective alternative to surgery. Radiother Oncol. 1998;48:15-21. (Pubitemid 28391963)
26. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462-7. (Pubitemid 26269945)
27. Marks LB, Munley MT, Bentel GC, Zhou SM, Hollis D, Scarfone C, et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys. 1997;39:563-70. (Pubitemid 27441420)
28. Anscher MS, Kong FM, Marks LB, Bentel GC, Jirtle RL. Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys. 1997;37:253-8. (Pubitemid 27138706)
29. Anscher MS, Kong FM, Jirtle R. The relevance of transforming growth factor beta 1 in pulmonary injury after radiation therapy. Lung Cancer. 1998;19:109-20. (Pubitemid 28161303)
30. Anscher MS, Kong FM, Andrews K. Plasma transforming growth factor b1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys. 1998;41:1029-35. (Pubitemid 28377483)
31. Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA, et al. Clinical dose-volume histogram analysis for pneu-monitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 1999;45:323-9. (Pubitemid 29408545)
32. Hernando ML, Marks LB, Bentel GC, Zhou SM, Hollis D, Das SK, et al. Radiation induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys. 2001;51:650-9.
33. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109-22.
34. Graham MV. Predicting radiation response [editorial]. Int J Radiat Oncol Biol Phys. 1997;39:561-2.
35. Graham MV, Drzymala RE, Jain NL. Confirmation of dose-volume histograms and normal tissue complication probability calculations to predict pulmonary complications after radiother-apy for lung cancer. Int J Radiat Oncol Biol Phys. 1994;30(Suppl 1):198.
36. Graham MV, Jain NL, Kahn MG, Drzymala RE, Purdy JA. Evaluation of an objective plan-evaluation model in the three-dimensional treatment of non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1996;34:469-74. (Pubitemid 26031594)
37. Oetzel D, Schraube P, Hensley F, Sroka-Pérez G, Menke M, Flentje M. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 1995;33:455-60.
38. Shi A, Zhu G, Wu H, Yu R, Li F, Xu B. Analysis of clinical and dosimetric factors associated with severe acute radiation pneu-monitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy. Radiat Oncol. 2010;5:1-8.